CV Sciences, Inc.'s CEO Releases Letter to Stockholders and Customers Regarding Complaint filed by Securities and Exchange Commission

Jun 19, 2017

CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND Meeting With FDA

Jun 19, 2017

CV Sciences, Inc. Presentation Now Available for On-Demand Viewing

Jun 5, 2017

CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017

May 30, 2017

CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

May 16, 2017

CV Sciences, Inc. Highlights WHO's World No Tobacco Day, May 31, 2017

May 8, 2017

CV Sciences, Inc. Announces Pre-IND Meeting Date with FDA

May 2, 2017

CV Sciences, Inc. Applauds U.S. Department of Defense Smokeless Tobacco Cessation Campaign

Mar 22, 2017

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil(TM), at Natural Products Expo West in Anaheim, CA - March 9-12, 2017

Feb 28, 2017

CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

Jan 25, 2017